{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:45:02Z","timestamp":1778564702368,"version":"3.51.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Central retinal artery occlusion (CRAO), an ocular stroke, causes severe and permanent visual impairment. Thrombolytic therapy is currently the main treatment option for CRAO. Intravenous thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) has been extensively applied in the treatment of CRAO with the proven advantages of effectiveness and safety. This meta-analysis aimed to assess the efficacy of intravenous rt-PA thrombolysis for the management of CRAO by evaluating the pooled evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature search of electronic databases including PubMed, OVID, and Cochrane Library was conducted up to and including March 2019. All studies reporting visual outcomes after CRAO with thrombolytic therapy were collected. Data on visual acuity and adverse events were recorded and assessed in this analysis. Data were inputted into the statistical software of STATA. The studies were weighed by the inverse of the variance and merged in a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The systematic review process yielded 7 eligible studies including 121 patients with CRAO who received the intravenous rt-PA treatment. Sixty-two patients showed improvement in visual acuity (52.0%; 95% CI, 34.0%\u201370.0%) following rt-PA intravenous thrombolytic therapy. The observed improvement rate in the intravenous rt-PA treatment group was significantly higher than the conservative treatment group (40.4% vs. 13.0%; OR\u200a=\u200a5.16; 95% CI, 1.90\u201314.05). The incidence rate of complications was relatively low (11 out of the 121 patients). Hemorrhage (9\/11) was the major reported complication. Mortality was zero.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>This meta-analysis indicated that intravenous rt-PA thrombolysis could be an effective and safe strategy for the management of CRAO. However, a more detailed large-scale clinical trial is warranted to strengthen the evidence-based therapeutic guidance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/scs.0000000000007134","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T23:21:22Z","timestamp":1604618482000},"page":"313-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Intravenous Recombinant Tissue-Type Plasminogen Activator Thrombolysis for Acute Central Retinal Artery Occlusion"],"prefix":"10.1097","volume":"32","author":[{"given":"Xiaotang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Honghui Hospital, Xi\u2019an Jiaotong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, the First Affiliated Hospital of Xi\u2019an Jiaotong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Suo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Xi\u2019an First Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Honghui Hospital, Xi\u2019an Jiaotong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixia","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Xi\u2019an Fourth Hospital, Xi\u2019an City, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runjia","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Xi\u2019an First Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Xi\u2019an Fourth Hospital, Xi\u2019an City, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Honghui Hospital, Xi\u2019an Jiaotong University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"R1-20250803","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"key":"R2-20250803","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/eye.2013.25","article-title":"A review of central retinal artery occlusion: clinical presentation and management","volume":"27","author":"Varma","year":"2013","journal-title":"Eye (Lond)"},{"key":"R3-20250803","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajo.2005.03.038","article-title":"Central retinal artery occlusion: visual outcome","volume":"140","author":"Hayreh","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R4-20250803","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00234-015-1588-3","article-title":"Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment","volume":"57","author":"Pielen","year":"2015","journal-title":"Neuroradiology"},{"key":"R5-20250803","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jnnp.2004.037135","article-title":"Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion","volume":"76","author":"Arnold","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-20250803","first-page":"1234","article-title":"Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion","volume":"120","author":"Kattah","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R7-20250803","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ajo.2008.06.016","article-title":"Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion","volume":"146","author":"Hattenbach","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R8-20250803","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","article-title":"Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial","volume":"42","author":"Chen","year":"2011","journal-title":"Stroke"},{"key":"R9-20250803","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/STROKEAHA.115.009839","article-title":"Retrobulbar spot sign predicts thrombolytic treatment effects and etiology in central retinal artery occlusion","volume":"46","author":"Nedelmann","year":"2015","journal-title":"Stroke"},{"key":"R10-20250803","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3892\/etm.2016.3681","article-title":"Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion","volume":"12","author":"Wu","year":"2016","journal-title":"Exp Ther Med"},{"key":"R11-20250803","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/1747493016687578","article-title":"Management of acute central retinal artery occlusion: intravenous thrombolysis is feasible and safe","volume":"12","author":"Pr\u00e9terre","year":"2017","journal-title":"Int J Stroke"},{"key":"R12-20250803","doi-asserted-by":"crossref","first-page":"e0198114","DOI":"10.1371\/journal.pone.0198114","article-title":"Intravenous thrombolysis in acute central retinal artery occlusion\u2014a prospective interventional case series","volume":"13","author":"Schultheiss","year":"2018","journal-title":"PLoS One"},{"key":"R13-20250803","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cpt.33","article-title":"Recombinant tissue plasminogen activators (rtPA): a review","volume":"97","author":"Gurman","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"R14-20250803","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in Meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"R15-20250803","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"R16-20250803","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R17-20250803","first-page":"CD000213","article-title":"Thrombolysis for acute ischaemic stroke","volume":"29","author":"Wardlaw","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20250803","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00076","article-title":"Intra-arterial thrombolysis for acute central retinal artery occlusion: a systematic review and meta-analysis","volume":"9","author":"Page","year":"2018","journal-title":"Front Neurol"},{"key":"R19-20250803","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/01.STR.0000202582.29510.6b","article-title":"Therapy of basilar artery occlusion a systematic analysis comparing intra-arterial and intravenous thrombolysis","volume":"37","author":"Lindsberg","year":"2006","journal-title":"Stroke"},{"key":"R20-20250803","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","article-title":"Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial","volume":"117","author":"Schumacher","year":"2010","journal-title":"Ophthalmology"},{"key":"R21-20250803","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/STROKEAHA.109.192535","article-title":"Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association\/American Stroke Association","volume":"40","author":"del Zoppo","year":"2009","journal-title":"Stroke"}],"container-title":["Journal of Craniofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SCS.0000000000007134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T17:36:07Z","timestamp":1754242567000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SCS.0000000000007134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/scs.0000000000007134","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.14173\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14173\/v2","asserted-by":"object"}]},"ISSN":["1049-2275","1536-3732"],"issn-type":[{"value":"1049-2275","type":"print"},{"value":"1536-3732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}